Research ArticleRheumatoid Arthritis
Open Access
Does Etanercept Biosimilar Prescription in a Rheumatology Center Bend the Medication Cost Curve?
Wieland D. Müskens, Sanne A.A. Rongen-van Dartel, Piet L.C.M. van Riel and Eddy M.M. Adang
The Journal of Rheumatology December 2021, 48 (12) 1803-1809; DOI: https://doi.org/10.3899/jrheum.200565
Wieland D. Müskens
1W.D. Müskens, MD, MSc, Department of IQ Healthcare, Radboudumc, Nijmegen;
Sanne A.A. Rongen-van Dartel
2S.A. Rongen-van Dartel, PhD, P.L. van Riel, MD, PhD, Department of IQ Healthcare, Radboudumc, Nijmegen, and Department of Rheumatology, Bernhoven, Uden;
Piet L.C.M. van Riel
2S.A. Rongen-van Dartel, PhD, P.L. van Riel, MD, PhD, Department of IQ Healthcare, Radboudumc, Nijmegen, and Department of Rheumatology, Bernhoven, Uden;
Eddy M.M. Adang
3E.M. Adang, PhD, Department of Health Evidence, Radboudumc, Nijmegen, the Netherlands.
In this issue
The Journal of Rheumatology
Vol. 48, Issue 12
1 Dec 2021
Does Etanercept Biosimilar Prescription in a Rheumatology Center Bend the Medication Cost Curve?
Wieland D. Müskens, Sanne A.A. Rongen-van Dartel, Piet L.C.M. van Riel, Eddy M.M. Adang
The Journal of Rheumatology Dec 2021, 48 (12) 1803-1809; DOI: 10.3899/jrheum.200565






